Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study.

Ferrara A, Mangione CM, Kim C, Marrero DG, Curb D, Stevens M, Selby JV; Translating Research Into Action for Diabetes Study Group.

Diabetes Care. 2008 Jan;31(1):69-74. Epub 2007 Oct 12.

2.

Cardiovascular risk in women with diabetes.

Rivellese AA, Riccardi G, Vaccaro O.

Nutr Metab Cardiovasc Dis. 2010 Jul;20(6):474-80. doi: 10.1016/j.numecd.2010.01.008. Review.

PMID:
20621459
3.

Cardiovascular risk in diabetes: a brief review.

Marks JB, Raskin P.

J Diabetes Complications. 2000 Mar-Apr;14(2):108-15. Review.

PMID:
10959073
4.

[Is cardiovascular risk different in the diabetic woman?].

Hanaire-Broutin H.

Diabetes Metab. 2001 Sep;27(4 Pt 2):S76-82. Review. French.

PMID:
11787442
5.

Women and heart disease: the role of diabetes and hyperglycemia.

Barrett-Connor E, Giardina EG, Gitt AK, Gudat U, Steinberg HO, Tschoepe D.

Arch Intern Med. 2004 May 10;164(9):934-42. Review.

PMID:
15136300
6.

[Guideline 'Cardiovascular Risk Management'].

Burgers JS, Simoons ML, Hoes AW, Stehouwer CD, Stalman WA.

Ned Tijdschr Geneeskd. 2007 May 12;151(19):1068-74. Review. Dutch.

PMID:
17552415
7.

Comorbidity complicates cardiovascular treatment: is diabetes the exception?

Nouwens E, van Lieshout J, Wensing M.

Neth J Med. 2012 Sep;70(7):298-305. Review.

8.

Lipids and CVD management: towards a global consensus.

Ballantyne C, Arroll B, Shepherd J.

Eur Heart J. 2005 Nov;26(21):2224-31. Epub 2005 Jun 21. Review.

PMID:
15972289
9.

Considerations for treating dyslipidemia in special diabetic populations.

Harmel AP.

Diabetes Metab Res Rev. 2002 Mar-Apr;18(2):88-95. Review.

PMID:
11994899
10.

Why is cardiovascular health important in menopausal women?

Simon T.

Climacteric. 2006 Sep;9 Suppl 1:13-8. Review.

PMID:
16899439
11.

Vascular complications in diabetes and their prevention.

Kassab E, McFarlane SI, Sower JR.

Vasc Med. 2001 Nov;6(4):249-55. Review.

PMID:
11958392
12.

Gender-specific aspects in the clinical presentation of cardiovascular disease.

Leuzzi C, Sangiorgi GM, Modena MG.

Fundam Clin Pharmacol. 2010 Dec;24(6):711-7. doi: 10.1111/j.1472-8206.2010.00873.x. Epub 2010 Sep 14. Review.

PMID:
20840353
13.

Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review.

Lanting LC, Joung IM, Mackenbach JP, Lamberts SW, Bootsma AH.

Diabetes Care. 2005 Sep;28(9):2280-8. Review.

PMID:
16123507
14.

Perceived gender bias in the treatment of cardiovascular disease.

Thurau R.

J Vasc Nurs. 1997 Dec;15(4):124-7. Review.

PMID:
9429381
15.

Cardiovascular diseases in women: an equal opportunity killer.

Morgan NA, Colling CL, Fye CL.

J Am Pharm Assoc (Wash). 1996 Jun;NS36(6):360-9. Review. Erratum in: J Am Pharm Assoc (Wash) 1996 Oct;NS36(10):564.

PMID:
8697261
16.

Residual lifetime risk of cardiovascular diseases in Japan.

Turin TC, Rumana N, Okamura T.

J Atheroscler Thromb. 2011;18(6):443-7. Epub 2011 Apr 21. Review.

17.

[Current topics (2005) in clinical cardiology: cardiovascular disease in women].

Murga Eizagaechevarria N, Pedreira Pérez M, Mazón Ramos P, Alonso García A.

Rev Esp Cardiol. 2006;59 Suppl 1:99-104. Review. Spanish.

18.

Sex differences in cardiovascular disease risk and exercise in type 2 diabetes.

Miller TM, Gilligan S, Herlache LL, Regensteiner JG.

J Investig Med. 2012 Apr;60(4):664-70. doi: 10.2310/JIM.0b013e31824b2de6. Review.

PMID:
22373663
19.
20.

Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros?

Segura J, Ruilope LM.

Diabetes Care. 2009 Nov;32 Suppl 2:S284-9. doi: 10.2337/dc09-S325. Review. No abstract available.

Supplemental Content

Support Center